Turnstone Biologics | 10-Q: Quarterly report

SEC announcementMay 13 16:10 · Announcements

Turnstone Biologics 1Q Loss/Shr 85c >TSBX

Turnstone Biologics 1Q Loss/Shr 85c >TSBX

Dow JonesMay 13 16:07

Turnstone Biologics Q1 EPS $(0.85) Misses $(0.78) Estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.78) by 8.97 percent.

BenzingaMay 13 16:05

Press Release: Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or th

Dow JonesMay 13 16:01

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to tr

GlobeNewswireMay 8 08:00

Turnstone Biologics Appoints William Waddill to Its Board of Directors

SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (NASDAQ:TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure

GlobeNewswireApr 16 08:00